References

Defining immune reset: achieving sustained remission in autoimmune diseases

10.1038/s41577-025-01141-w · 2025 · External reference

Immune reset and immune retune: approaching cure?

10.1038/s41584-026-01357-7 · 2026 · External reference

Resetting autoimmune disease with CAR cell therapies

10.1038/s41591-026-04430-6 · 2026 · External reference

Depletion of B cells in murine lupus: efficacy and resistance

10.4049/jimmunol.179.5.3351 · 2007 · External reference

The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy

10.1084/jem.20040119 · 2004 · External reference

The essential roles of memory B cells in the pathogenesis of systemic lupus erythematosus

10.1038/s41584-024-01179-5 · 2024 · External reference

Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification

10.1136/annrheumdis-2015-208140 · 2016 · External reference

Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease

10.1038/ni.3579 · 2017 · External reference

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis

10.1001/jama.2014.6368 · 2014 · External reference

Myeloablative autologous stem-cell transplantation for severe scleroderma

10.1056/nejmoa1703327 · 2018 · External reference

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

10.1038/s41591-022-02017-5 · 2022 · External reference

CD19 CAR T-cell therapy in autoimmune disease - a case series with follow-up

10.1056/nejmoa2308917 · 2024 · External reference

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus

10.1016/j.ard.2025.06.2132 · 2026 · External reference

Effects of different B-cell-depleting strategies on the lymphatic tissue

10.1016/j.ard.2025.06.2120 · 2025 · External reference

Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial

10.1038/s41591-025-03937-8 · 2025 · External reference

Distinct autoreactive CD19(-) plasma cell subsets accumulate in lupus-prone mice

10.1038/s41467-025-65906-6 · 2025 · External reference

EULAR recommendations for the treatment of systemic sclerosis: 2023 update

10.1136/ard-2024-226430 · 2025 · External reference

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

10.1136/ard-2023-224762 · 2024 · External reference

EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update

10.1136/ard-2022-223764 · 2024 · External reference